CME Group (NASDAQ:CME) – Equities research analysts at Jefferies Group issued their Q2 2018 EPS estimates for shares of CME Group in a note issued to investors on Tuesday, April 10th. Jefferies Group analyst D. Fannon forecasts that the financial services provider will post earnings of $1.64 per share for the quarter. Jefferies Group also issued estimates for CME Group’s Q3 2018 earnings at $1.60 EPS, Q4 2018 earnings at $1.57 EPS, FY2018 earnings at $6.65 EPS and FY2019 earnings at $6.87 EPS.
CME Group (NASDAQ:CME) last issued its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.10 by $0.02. The firm had revenue of $900.00 million for the quarter, compared to analysts’ expectations of $886.85 million. CME Group had a return on equity of 7.68% and a net margin of 111.49%. The firm’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.14 earnings per share.
A number of other brokerages have also recently commented on CME. ValuEngine cut CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 7th. Zacks Investment Research cut CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 6th. Bank of America boosted their price objective on CME Group from $175.00 to $185.00 and gave the stock a “buy” rating in a research note on Thursday, March 8th. BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a research note on Thursday, March 15th. Finally, Barclays boosted their price objective on CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a research note on Friday, February 2nd. Three analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $165.57.
Shares of CME opened at $163.42 on Friday. The stock has a market cap of $55,894.63, a price-to-earnings ratio of 34.26, a P/E/G ratio of 2.28 and a beta of 0.56. CME Group has a 12 month low of $114.82 and a 12 month high of $171.71. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.03 and a current ratio of 1.03.
The firm also recently announced a quarterly dividend, which was paid on Monday, March 26th. Stockholders of record on Friday, March 9th were given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.71%. This is a positive change from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Thursday, March 8th. CME Group’s payout ratio is presently 58.70%.
In other news, Chairman Terrence A. Duffy sold 20,000 shares of CME Group stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $151.66, for a total transaction of $3,033,200.00. Following the sale, the chairman now directly owns 99,239 shares of the company’s stock, valued at $15,050,586.74. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Derek Sammann sold 2,400 shares of CME Group stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $161.66, for a total value of $387,984.00. Following the sale, the insider now directly owns 40,153 shares in the company, valued at $6,491,133.98. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 35,699 shares of company stock worth $5,532,362. Corporate insiders own 0.57% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in CME. Cambridge Investment Research Advisors Inc. increased its holdings in CME Group by 63.6% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 11,497 shares of the financial services provider’s stock valued at $1,679,000 after buying an additional 4,470 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its holdings in CME Group by 3.2% in the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 202,656 shares of the financial services provider’s stock valued at $29,598,000 after buying an additional 6,352 shares during the last quarter. GUARDCAP ASSET MANAGEMENT Ltd bought a new stake in CME Group in the fourth quarter valued at about $15,371,000. Hilton Capital Management LLC increased its holdings in CME Group by 12.0% in the fourth quarter. Hilton Capital Management LLC now owns 87,750 shares of the financial services provider’s stock valued at $12,816,000 after buying an additional 9,386 shares during the last quarter. Finally, OLD Mutual Customised Solutions Proprietary Ltd. increased its holdings in CME Group by 50.5% in the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 18,190 shares of the financial services provider’s stock valued at $2,657,000 after buying an additional 6,100 shares during the last quarter. 83.12% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This report was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://ledgergazette.com/2018/04/15/cme-group-to-post-q2-2018-earnings-of-1-64-per-share-jefferies-group-forecasts-cme.html.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.